O	0	8	Systemic	Systemic	JJ	B-NP
O	9	19	regulation	regulation	NN	I-NP
O	20	22	of	of	IN	B-PP
O	23	34	distraction	distraction	NN	B-NP
O	35	47	osteogenesis	osteogenesis	NN	I-NP
O	47	48	:	:	:	O
O	49	50	a	a	DT	B-NP
O	51	58	cascade	cascade	NN	I-NP
O	59	61	of	of	IN	B-PP
O	62	73	biochemical	biochemical	JJ	B-NP
O	74	81	factors	factor	NNS	I-NP
O	81	82	.	.	.	O

O	83	87	This	This	DT	B-NP
O	88	93	study	study	NN	I-NP
O	94	106	investigates	investigate	VBZ	B-VP
O	107	110	the	the	DT	B-NP
O	111	119	systemic	systemic	JJ	I-NP
O	120	131	biochemical	biochemical	JJ	I-NP
O	132	142	regulation	regulation	NN	I-NP
O	143	145	of	of	IN	B-PP
O	146	154	fracture	fracture	NN	B-NP
O	155	162	healing	healing	NN	I-NP
O	163	165	in	in	IN	B-PP
O	166	177	distraction	distraction	NN	B-NP
O	178	190	osteogenesis	osteogenesis	NN	I-NP
O	191	199	compared	compare	VBN	B-PP
O	200	204	with	with	IN	B-PP
O	205	210	rigid	rigid	JJ	B-NP
O	211	220	osteotomy	osteotomy	NN	I-NP
O	221	223	in	in	IN	B-PP
O	224	225	a	a	DT	B-NP
O	226	237	prospective	prospective	JJ	I-NP
O	238	240	in	in	FW	I-NP
O	241	245	vivo	vivo	FW	I-NP
O	246	251	study	study	NN	I-NP
O	252	254	in	in	IN	B-PP
O	255	261	humans	human	NNS	B-NP
O	261	262	.	.	.	O

O	263	265	To	To	TO	B-VP
O	266	273	further	further	RB	I-VP
O	274	281	clarify	clarify	VB	I-VP
O	282	285	the	the	DT	B-NP
O	286	295	influence	influence	NN	I-NP
O	296	298	of	of	IN	B-PP
O	299	309	mechanical	mechanical	JJ	B-NP
O	310	316	strain	strain	NN	I-NP
O	317	319	on	on	IN	B-PP
O	320	323	the	the	DT	B-NP
O	324	334	regulation	regulation	NN	I-NP
O	335	337	of	of	IN	B-PP
B-Organ	338	342	bone	bone	NN	B-NP
O	343	352	formation	formation	NN	I-NP
O	352	353	,	,	,	O
B-Organ	354	358	bone	bone	NN	B-NP
O	359	365	growth	growth	NN	I-NP
O	366	373	factors	factor	NNS	I-NP
O	374	375	(	(	(	O
O	375	382	insulin	insulin	NN	B-NP
O	382	383	-	-	HYPH	O
O	383	387	like	like	JJ	B-NP
O	388	394	growth	growth	NN	I-NP
O	395	401	factor	factor	NN	I-NP
O	402	403	[	[	(	O
O	403	406	IGF	IGF	NN	B-NP
O	406	407	]	]	)	I-NP
O	408	409	I	I	NN	I-NP
O	409	410	,	,	,	O
O	411	414	IGF	IGF	NN	B-NP
O	415	422	binding	binding	NN	I-NP
O	423	430	protein	protein	NN	I-NP
O	431	432	[	[	(	I-NP
O	432	437	IGFBP	IGFBP	NN	I-NP
O	437	438	]	]	)	I-NP
O	439	440	3	3	CD	I-NP
O	440	441	,	,	,	O
O	442	454	transforming	transform	VBG	B-VP
O	455	461	growth	growth	NN	B-NP
O	462	468	factor	factor	NN	I-NP
O	469	470	[	[	(	O
O	470	473	TGF	TGF	NN	B-NP
O	473	474	]	]	)	O
O	475	480	beta1	beta1	NN	B-NP
O	480	481	,	,	,	O
O	482	485	and	and	CC	O
O	486	491	basic	basic	JJ	B-NP
O	492	495	FGF	FGF	NN	I-NP
O	496	497	[	[	(	O
O	497	501	bFGF	bFGF	NN	B-NP
O	501	502	]	]	)	O
O	502	503	)	)	)	O
O	503	504	,	,	,	O
B-Cellular_component	505	509	bone	bone	NN	B-NP
I-Cellular_component	510	516	matrix	matrix	NN	I-NP
O	517	526	degrading	degrade	VBG	B-VP
O	527	534	enzymes	enzyme	NNS	B-NP
O	535	536	(	(	(	O
O	536	542	matrix	matrix	NN	B-NP
O	542	543	-	-	HYPH	I-NP
O	543	561	metalloproteinases	metalloproteinas	NNS	I-NP
O	562	563	[	[	(	O
O	563	567	MMPs	MMP	NNS	B-NP
O	567	568	]	]	)	O
O	569	570	1	1	CD	B-NP
O	570	571	,	,	,	I-NP
O	572	573	2	2	CD	I-NP
O	573	574	,	,	,	O
O	575	578	and	and	CC	O
O	579	580	3	3	CD	B-NP
O	580	581	)	)	)	O
O	581	582	,	,	,	O
O	583	588	human	human	JJ	B-NP
O	589	595	growth	growth	NN	I-NP
O	596	603	hormone	hormone	NN	I-NP
O	604	605	(	(	(	O
O	605	608	hGH	hGH	NN	B-NP
O	608	609	)	)	)	O
O	609	610	,	,	,	O
O	611	614	and	and	CC	O
B-Organ	615	619	bone	bone	NN	B-NP
O	620	629	formation	formation	NN	I-NP
O	630	637	markers	marker	NNS	I-NP
O	638	639	(	(	(	O
O	639	642	ALP	ALP	NN	B-NP
O	642	643	,	,	,	O
B-Organ	644	648	bone	bone	NN	B-NP
O	648	649	-	-	HYPH	B-NP
O	649	657	specific	specific	JJ	I-NP
O	658	661	ALP	ALP	NN	I-NP
O	662	663	[	[	(	O
O	663	666	BAP	BAP	NN	B-NP
O	666	667	]	]	)	O
O	667	668	,	,	,	O
O	669	672	and	and	CC	O
O	673	684	osteocalcin	osteocalcin	NN	B-NP
O	685	686	[	[	(	O
O	686	688	OC	OC	NN	B-NP
O	688	689	]	]	)	O
O	689	690	)	)	)	O
O	691	695	have	have	VBP	B-VP
O	696	700	been	be	VBN	I-VP
O	701	709	analyzed	analyze	VBN	I-VP
O	710	712	in	in	IN	B-PP
B-Organism_substance	713	718	serum	serum	NN	B-NP
I-Organism_substance	719	726	samples	sample	NNS	I-NP
O	727	731	from	from	IN	B-PP
O	732	734	10	10	CD	B-NP
O	735	743	patients	patient	NNS	I-NP
O	744	746	in	in	IN	B-PP
O	747	751	each	each	DT	B-NP
O	752	757	group	group	NN	I-NP
O	758	761	pre	pre	AFX	O
O	761	762	-	-	HYPH	O
O	763	766	and	and	CC	O
O	767	782	postoperatively	postoperatively	RB	B-ADVP
O	782	783	.	.	.	O

O	784	786	In	In	IN	B-PP
O	787	790	the	the	DT	B-NP
O	791	802	distraction	distraction	NN	I-NP
O	803	808	group	group	NN	I-NP
O	808	809	,	,	,	O
O	810	811	a	a	DT	B-NP
O	812	823	significant	significant	JJ	I-NP
O	824	837	postoperative	postoperative	JJ	I-NP
O	838	846	increase	increase	NN	I-NP
O	847	849	in	in	IN	B-PP
O	850	853	MMP	MMP	NN	B-NP
O	853	854	-	-	HYPH	B-NP
O	854	855	1	1	CD	I-NP
O	855	856	,	,	,	O
O	857	861	bFGF	bFGF	NN	B-NP
O	861	862	,	,	,	O
O	863	866	ALP	ALP	NN	B-NP
O	866	867	,	,	,	O
O	868	871	and	and	CC	O
O	872	875	BAP	BAP	NN	B-NP
O	876	881	could	could	MD	B-VP
O	882	884	be	be	VB	I-VP
O	885	893	observed	observe	VBN	I-VP
O	894	900	during	during	IN	B-PP
O	901	904	the	the	DT	B-NP
O	905	916	lengthening	lengthening	NN	I-NP
O	917	920	and	and	CC	O
O	921	924	the	the	DT	B-NP
O	925	938	consolidation	consolidation	NN	I-NP
O	939	945	period	period	NN	I-NP
O	946	950	when	when	WRB	B-ADVP
O	951	959	compared	compare	VBN	B-PP
O	960	964	with	with	IN	B-PP
O	965	968	the	the	DT	B-NP
O	969	977	baseline	baseline	NN	I-NP
O	978	984	levels	level	NNS	I-NP
O	984	985	.	.	.	O

O	986	995	Osteotomy	Osteotomy	NN	B-NP
O	996	1004	fracture	fracture	NN	I-NP
O	1005	1012	healing	heal	VBG	B-VP
O	1013	1020	without	without	IN	B-PP
O	1021	1024	the	the	DT	B-NP
O	1025	1033	traction	traction	NN	I-NP
O	1034	1042	stimulus	stimulus	NN	I-NP
O	1043	1049	failed	fail	VBD	B-VP
O	1050	1052	to	to	TO	I-VP
O	1053	1059	induce	induce	VB	I-VP
O	1060	1061	a	a	DT	B-NP
O	1062	1075	corresponding	corresponding	JJ	I-NP
O	1076	1084	increase	increase	NN	I-NP
O	1085	1087	in	in	IN	B-PP
O	1088	1093	these	these	DT	B-NP
O	1094	1101	factors	factor	NNS	I-NP
O	1101	1102	.	.	.	O

O	1103	1105	In	In	IN	B-PP
O	1106	1114	addition	addition	NN	B-NP
O	1114	1115	,	,	,	O
O	1116	1126	comparison	comparison	NN	B-NP
O	1127	1129	of	of	IN	B-PP
O	1130	1134	both	both	DT	B-NP
O	1135	1141	groups	group	NNS	I-NP
O	1142	1150	revealed	reveal	VBD	B-VP
O	1151	1152	a	a	DT	B-NP
O	1153	1166	significantly	significantly	RB	I-NP
O	1167	1173	higher	high	JJR	I-NP
O	1174	1182	increase	increase	NN	I-NP
O	1183	1185	in	in	IN	B-PP
O	1186	1189	TGF	TGF	NN	B-NP
O	1189	1190	-	-	HYPH	B-NP
O	1190	1195	beta1	beta1	NN	I-NP
O	1195	1196	,	,	,	O
O	1197	1200	IGF	IGF	NN	B-NP
O	1200	1201	-	-	HYPH	I-NP
O	1201	1202	I	I	NN	I-NP
O	1202	1203	,	,	,	O
O	1204	1209	IGFBP	IGFBP	NN	B-NP
O	1209	1210	-	-	HYPH	B-NP
O	1210	1211	3	3	CD	I-NP
O	1211	1212	,	,	,	O
O	1213	1216	and	and	CC	O
O	1217	1220	hGH	hGH	NN	B-NP
O	1221	1223	in	in	IN	B-PP
O	1224	1227	the	the	DT	B-NP
O	1228	1239	lengthening	lengthening	NN	I-NP
O	1240	1245	group	group	NN	I-NP
O	1246	1252	during	during	IN	B-PP
O	1253	1256	the	the	DT	B-NP
O	1257	1268	distraction	distraction	NN	I-NP
O	1269	1275	period	period	NN	I-NP
O	1275	1276	,	,	,	O
O	1277	1287	indicating	indicate	VBG	B-VP
O	1288	1291	key	key	JJ	B-NP
O	1292	1302	regulatory	regulatory	JJ	I-NP
O	1303	1312	functions	function	NNS	I-NP
O	1313	1315	in	in	IN	B-PP
O	1316	1335	mechanotransduction	mechanotransduction	NN	B-NP
O	1335	1336	.	.	.	O

O	1337	1340	The	The	DT	B-NP
O	1341	1345	time	time	NN	I-NP
O	1346	1353	courses	course	NNS	I-NP
O	1354	1356	of	of	IN	B-PP
O	1357	1364	changes	change	NNS	B-NP
O	1365	1367	in	in	IN	B-PP
O	1368	1371	MMP	MMP	NN	B-NP
O	1371	1372	-	-	HYPH	B-NP
O	1372	1373	1	1	CD	I-NP
O	1373	1374	,	,	,	O
B-Organ	1375	1379	bone	bone	NN	B-NP
O	1380	1386	growth	growth	NN	I-NP
O	1387	1394	factors	factor	NNS	I-NP
O	1395	1396	(	(	(	O
O	1396	1399	TGF	TGF	NN	B-NP
O	1399	1400	-	-	HYPH	O
O	1400	1405	beta1	beta1	NN	B-NP
O	1406	1409	and	and	CC	O
O	1410	1414	bFGF	bFGF	NN	B-NP
O	1414	1415	)	)	)	O
O	1415	1416	,	,	,	O
O	1417	1420	and	and	CC	O
O	1421	1424	hGH	hGH	NN	B-NP
O	1424	1425	,	,	,	O
O	1426	1438	respectively	respectively	RB	B-ADVP
O	1438	1439	,	,	,	O
O	1440	1450	correlated	correlate	VBD	B-VP
O	1451	1464	significantly	significantly	RB	B-ADVP
O	1465	1471	during	during	IN	B-PP
O	1472	1475	the	the	DT	B-NP
O	1476	1487	lengthening	lengthening	NN	I-NP
O	1488	1493	phase	phase	NN	I-NP
O	1493	1494	,	,	,	O
O	1495	1505	indicating	indicate	VBG	B-VP
O	1506	1512	common	common	JJ	B-NP
O	1513	1523	regulatory	regulatory	JJ	I-NP
O	1524	1532	pathways	pathway	NNS	I-NP
O	1533	1536	for	for	IN	B-PP
O	1537	1542	these	these	DT	B-NP
O	1543	1550	factors	factor	NNS	I-NP
O	1551	1553	in	in	IN	B-PP
O	1554	1565	distraction	distraction	NN	B-NP
O	1566	1578	osteogenesis	osteogenesis	NN	I-NP
O	1578	1579	.	.	.	O

O	1580	1591	Significant	Significant	JJ	B-NP
O	1592	1603	correlation	correlation	NN	I-NP
O	1604	1611	between	between	IN	B-PP
O	1612	1615	the	the	DT	B-NP
O	1616	1628	osteoblastic	osteoblastic	JJ	I-NP
O	1629	1635	marker	marker	NN	I-NP
O	1636	1639	BAP	BAP	NN	I-NP
O	1639	1640	,	,	,	O
O	1641	1644	TGF	TGF	NN	B-NP
O	1644	1645	-	-	HYPH	B-NP
O	1645	1650	beta1	beta1	NN	I-NP
O	1650	1651	,	,	,	O
O	1652	1655	and	and	CC	O
O	1656	1660	bFGF	bFGF	NN	B-NP
O	1661	1669	suggests	suggest	VBZ	B-VP
O	1670	1676	strain	strain	NN	B-NP
O	1676	1677	-	-	HYPH	B-NP
O	1677	1686	activated	activate	VBN	I-NP
B-Cell	1687	1699	osteoblastic	osteoblastic	JJ	I-NP
I-Cell	1700	1705	cells	cell	NNS	I-NP
O	1706	1708	as	as	IN	B-PP
O	1709	1710	a	a	DT	B-NP
O	1711	1716	major	major	JJ	I-NP
O	1717	1723	source	source	NN	I-NP
O	1724	1726	of	of	IN	B-PP
O	1727	1739	systemically	systemically	RB	B-NP
O	1740	1749	increased	increase	VBN	I-NP
B-Organ	1750	1754	bone	bone	NN	I-NP
O	1755	1761	growth	growth	NN	I-NP
O	1762	1769	factors	factor	NNS	I-NP
O	1770	1776	during	during	IN	B-PP
O	1777	1783	callus	callus	NN	B-NP
O	1784	1795	distraction	distraction	NN	I-NP
O	1795	1796	.	.	.	O

O	1797	1800	The	The	DT	B-NP
O	1801	1809	systemic	systemic	JJ	I-NP
O	1810	1818	increase	increase	NN	I-NP
O	1819	1821	in	in	IN	B-PP
O	1822	1826	bFGF	bFGF	NN	B-NP
O	1827	1830	and	and	CC	I-NP
O	1831	1834	MMP	MMP	NN	I-NP
O	1834	1835	-	-	HYPH	B-NP
O	1835	1836	1	1	CD	I-NP
O	1837	1842	might	might	MD	B-VP
O	1843	1850	reflect	reflect	VB	I-VP
O	1851	1853	an	an	DT	B-NP
O	1854	1863	increased	increase	VBN	I-NP
O	1864	1869	local	local	JJ	I-NP
O	1870	1881	stimulation	stimulation	NN	I-NP
O	1882	1884	of	of	IN	B-PP
O	1885	1897	angiogenesis	angiogenesis	NN	B-NP
O	1898	1904	during	during	IN	B-PP
O	1905	1916	distraction	distraction	NN	B-NP
O	1917	1929	osteogenesis	osteogenesis	NN	I-NP
O	1929	1930	.	.	.	O

